Novo Nordisk
NVO
#109
Rank
โ‚น15.937 T
Marketcap
โ‚น3,616
Share price
-1.42%
Change (1 day)
-16.60%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.144 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.43 Billion. In 2025 the company made an earning of โ‚น1.950 Trillion, an increase over its 2024 earnings that were of โ‚น1.834 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.144 T9.99%
2025 โ‚น1.950 T6.28%
2024 โ‚น1.834 T28.01%
2023 โ‚น1.433 T57.81%
2022 โ‚น908.26 B5.24%
2021 โ‚น863.07 B12.38%
2020 โ‚น767.97 B13.11%
2019 โ‚น678.97 B-3.45%
2018 โ‚น703.23 B1.88%
2017 โ‚น690.23 B4.3%
2016 โ‚น661.75 B10.32%
2015 โ‚น599.84 B7.47%
2014 โ‚น558.16 B3.4%
2013 โ‚น539.80 B19.09%
2012 โ‚น453.28 B15.58%
2011 โ‚น392.19 B16.58%
2010 โ‚น336.42 B25.66%
2009 โ‚น267.73 B10.68%
2008 โ‚น241.90 B55.82%
2007 โ‚น155.24 B7.02%
2006 โ‚น145.06 B19.05%
2005 โ‚น121.84 B10.55%
2004 โ‚น110.21 B
2002 โ‚น72.92 B-14.39%
2001 โ‚น85.17 B-52.82%
2000 โ‚น180.51 B250%
1999 โ‚น51.57 B31.21%
1998 โ‚น39.30 B34.31%
1997 โ‚น29.26 B11.46%
1996 โ‚น26.25 B9.03%
1995 โ‚น24.07 B-3.15%
1994 โ‚น24.86 B-0.67%
1993 โ‚น25.03 B45.38%
1992 โ‚น17.21 B-13.81%
1991 โ‚น19.97 B37.12%
1990 โ‚น14.56 B-0.79%
1989 โ‚น14.68 B26.2%
1988 โ‚น11.63 B24.97%
1987 โ‚น9.31 B-0.9%
1986 โ‚น9.39 B-7.78%
1985 โ‚น10.18 B24.87%
1984 โ‚น8.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น648.23 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.234 T 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น724.52 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น1.054 T-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA